Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41
about
Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsHIV-1 neutralizing antibodies: understanding nature's pathwaysHIV-1 antibodies from infection and vaccination: insights for guiding vaccine designA gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen RecognitionStructure and Immunogenicity of a Peptide Vaccine, Including the Complete HIV-1 gp41 2F5 EpitopeRecognition of membrane-bound fusion-peptide/MPER complexes by the HIV-1 neutralizing 2F5 antibody: implications for anti-2F5 immunogenicityImmunogenicity of membrane-bound HIV-1 gp41 membrane-proximal external region (MPER) segments is dominated by residue accessibility and modulated by stereochemistry.Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity.Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and MacaquesAutoreactivity in HIV-1 broadly neutralizing antibodies: implications for their function and induction by vaccination.Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodiesStructure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides.Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunizationThe Atomic Structure of the HIV-1 gp41 Transmembrane Domain and Its Connection to the Immunogenic Membrane-proximal External RegionImmunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external regionCrystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion.Neutralizing antibodies to HIV-1 induced by immunization.Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure.Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineagesMechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif.Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies.Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design.Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies.New approaches to HIV vaccine development.HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies.HIV-1 antibodies and vaccine antigen selectively interact with lipid domains.How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design.Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target.Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responses.The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects.DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity.Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Circumsporozoite Protein AntigensA Comprehensive Analysis of the T and B Lymphocytes Repertoire Shaped by HIV Vaccines
P2860
Q26996159-71C17FD2-4B3E-4554-BB19-79C30DF92F3BQ27000480-F2A973CE-5F8B-4CB3-B33E-28FF42785DB0Q27022055-7221C925-8A6D-49C8-A41B-5154D5592359Q27676864-220EFC98-7824-42FB-BCAB-6394D5FCC6B1Q27681352-5CFC58BE-ABF7-49DA-B290-522D396F5B28Q28484544-584D4062-C9D1-4537-8D5D-CF7FFBAAFC9CQ30353709-4C0A3213-EFE3-4437-AF1D-FAEEF22C71F9Q30391094-B2025EF6-FB37-443F-A979-7BE300C57299Q33683203-9EC36EDC-1A1C-4C78-8C37-64F48F44D463Q34022578-ED380BA3-26E7-496A-931B-DD25CC0A5E16Q34324992-5D35E8CE-3E02-499A-918C-D057F6ADAD90Q34350894-CD90FB1D-394A-4C21-9A3F-59318FFEB09DQ34396912-DE9E74C9-B8F5-472A-BA8C-34CA272D1787Q34988326-327DC915-FFD2-4949-B7C6-33820AB057B2Q35034311-4F48D0CE-5737-4EB5-B6C7-50B5DB03AF00Q35487441-D2323500-9ECA-4EDB-8DC5-3354C0545995Q35860914-87E37013-FE74-4F11-92AE-4CF2A7178AABQ35960908-0DB98DEF-AC8B-4B0F-95D9-B8D9A2FBB164Q36372534-E46557C7-9A0A-4D2E-B145-430AA9343317Q36485204-22C6CC2C-53E7-42F6-B1D8-841555D313CCQ36559838-73BD4AE8-905E-400F-A28A-5397C52068FFQ36603515-AE9F2ACD-F053-49C3-AEEE-9B9743F6B477Q36978277-EAE0F9CF-0CB9-4843-A880-9969C8A36A8BQ37221575-11C91A77-4948-497E-84F4-5F3884E2C649Q37547462-B442DA50-5D95-4B28-B940-9D948ADB2223Q37584635-D8FDEB28-17D1-487A-9CA5-3BE3A4F788ABQ37607358-3387A28B-5D2A-4621-8B50-44371EEC8717Q38072056-0F22F8BA-BFFC-4F70-A862-E994792D1E94Q38220506-8B3B60E6-ABC6-4506-B8C0-39B440DA2941Q38521826-680BA140-B57C-4E31-8AB7-E09C9D424216Q38665463-A8197B06-C474-40EF-9832-AF7188A877B6Q38975605-5678482E-1CE4-42E2-BC97-26E136C671CEQ39250593-3FAEB2E0-71B9-4A73-95A6-BD6C95A6C6E6Q41925820-A3B2B5EA-FE81-43A1-A17C-16358DDE0575Q42278743-AD1BA637-D711-42D2-845E-7D218AB2CD6EQ52581587-71A79E1E-A969-4CAE-82F5-B23282F623F9Q52729536-7DF24726-4D71-4F0B-8E3B-85C9A50D0462Q56342409-9058C7EF-9FBD-407D-A57E-C9E4DBAD1621Q57491418-23B44CCF-AA8A-49F5-8A1B-F6D4F1F95536
P2860
Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Induction of antibodies in rhe ...... ate conformation of HIV-1 gp41
@ast
Induction of antibodies in rhe ...... ate conformation of HIV-1 gp41
@en
Induction of antibodies in rhe ...... ate conformation of HIV-1 gp41
@nl
type
label
Induction of antibodies in rhe ...... ate conformation of HIV-1 gp41
@ast
Induction of antibodies in rhe ...... ate conformation of HIV-1 gp41
@en
Induction of antibodies in rhe ...... ate conformation of HIV-1 gp41
@nl
prefLabel
Induction of antibodies in rhe ...... ate conformation of HIV-1 gp41
@ast
Induction of antibodies in rhe ...... ate conformation of HIV-1 gp41
@en
Induction of antibodies in rhe ...... ate conformation of HIV-1 gp41
@nl
P2093
P2860
P3181
P1433
P1476
Induction of antibodies in rhe ...... ate conformation of HIV-1 gp41
@en
P2093
Cindy Bowman
Frederick H Jaeger
Gilad Ofek
Hua-Xin Liao
Kara M Anasti
Laura L Sutherland
Norman L Letvin
Peter D Kwong
Richard M Scearce
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0027824
P407
P577
2011-01-01T00:00:00Z